Gaithersburg, MD, United States of America

Kathryn Shoemaker

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathryn Shoemaker. Retrieved from https://idiyas.com/inventor/kathryn-shoemaker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathryn Shoemaker: Innovator in Infection Control

Introduction

Kathryn Shoemaker is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of infection control, particularly through her innovative methods aimed at treating patients colonized with harmful bacteria.

Latest Patents

Kathryn holds a patent for her work titled "Decreasing infections in colonized patients." This patent focuses on methods of treating subjects colonized with an anti-alpha toxin antibody or antigen-binding fragment thereof. The methods outlined in her patent can effectively decrease the incidence of infection associated with the presence of the subject.

Career Highlights

Kathryn is currently employed at MedImmune Limited, where she continues to advance her research and development efforts. Her work has been instrumental in addressing critical health challenges related to infections.

Collaborations

Throughout her career, Kathryn has collaborated with notable colleagues, including Alexey Ruzin and Bret Sellman. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Kathryn Shoemaker is a dedicated inventor whose work in infection control has the potential to make a significant impact on patient care. Her innovative approaches and collaborations highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…